The Georgetown CERSI responds to a growing public health need to ensure that the workforce at the U.S. Food and Drug Administration (FDA) has ready access to education and training opportunities. The CERSI will open to FDA scientists and staff a broad array of continuing education and professional development in the fields of medicine, nursing, and law.
Georgetown faculty are engaging with the CERSI to create new courses; researchers creating and participating in newly established regulatory science projects; and students have the opportunity to participate in research projects, take courses and pursue potential career paths in regulatory science. FDA has the opportunity to participate as both learners and teachers.
Education & Training Resources
Regulatory Science education and training at Georgetown University is based on a curriculum that integrates the Competencies for Regulatory Science developed through a multi-stakeholder effort. Education and training programs use core competencies to define the knowledge, skills, and abilities that trainees are expected to develop. Competencies assist in designing curricula, experiential learning opportunities, and other training methods, as well as developing metrics to track outcomes to assess whether objectives are met. Competencies for Regulatory Science establish standards for the field and help to ensure that our programs meet high-quality and recognized benchmarks.
Because many different organizations are invested in regulatory science education and training, and contribute to a growing body of material, we maintain a catalog of education and training resources on our website.
The catalog is not exhaustive and is meant to provide a starting point for those who are interested in learning more about regulatory science, research, and related disciplines.
The GU CERSI is also joining with the NIH-supported Georgetown–Howard Universities Center for Clinical and Translational Science (GHUCCTS), which supports GUMC and its partners with human resources and infrastructure to advance the development of innovative medical products.